Published in Ann N Y Acad Sci on June 01, 2010
MRI investigation of the sensorimotor cortex and the corticospinal tract after acute spinal cord injury: a prospective longitudinal study. Lancet Neurol (2013) 2.06
Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol (2012) 1.60
Nogo limits neural plasticity and recovery from injury. Curr Opin Neurobiol (2014) 1.42
Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia. Cold Spring Harb Perspect Biol (2014) 1.36
Role of the lesion scar in the response to damage and repair of the central nervous system. Cell Tissue Res (2012) 1.21
Recovery from chronic spinal cord contusion after Nogo receptor intervention. Ann Neurol (2011) 1.18
Where no synapses go: gatekeepers of circuit remodeling and synaptic strength. Trends Neurosci (2013) 1.11
Spinal cord injury: a review of current therapy, future treatments, and basic science frontiers. Neurochem Res (2013) 1.08
Conduction failure following spinal cord injury: functional and anatomical changes from acute to chronic stages. J Neurosci (2011) 1.04
Plasticity after spinal cord injury: relevance to recovery and approaches to facilitate it. Neurotherapeutics (2011) 1.02
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation. Brain (2012) 0.98
Intracerebroventricularly delivered VEGF promotes contralesional corticorubral plasticity after focal cerebral ischemia via mechanisms involving anti-inflammatory actions. Neurobiol Dis (2011) 0.89
Finding an optimal rehabilitation paradigm after stroke: enhancing fiber growth and training of the brain at the right moment. Front Hum Neurosci (2014) 0.86
Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury. J Control Release (2015) 0.85
How hard is the CNS hardware? Nat Neurosci (2010) 0.83
Drug research: plug the real brain drain. Nature (2012) 0.82
Extrinsic and intrinsic regulation of axon regeneration at a crossroads. Front Mol Neurosci (2015) 0.82
High affinity sialoside ligands of myelin associated glycoprotein. Bioorg Med Chem Lett (2011) 0.81
Therapeutics targeting Nogo-A hold promise for stroke restoration. CNS Neurol Disord Drug Targets (2013) 0.80
Spinal cord injury - there is not just one way of treating it. F1000Prime Rep (2014) 0.79
Translational spinal cord injury research: preclinical guidelines and challenges. Handb Clin Neurol (2012) 0.78
Cellular therapies for treating pain associated with spinal cord injury. J Transl Med (2012) 0.76
Nogo-A Neutralization Improves Graft Function in a Rat Model of Parkinson's Disease. Front Cell Neurosci (2016) 0.75
Anti-Nogo-A Immunotherapy Does Not Alter Hippocampal Neurogenesis after Stroke in Adult Rats. Front Neurosci (2016) 0.75
Increased Brain Sensorimotor Network Activation after Incomplete Spinal Cord Injury. J Neurotrauma (2016) 0.75
Guest editorial: Opportunities in rehabilitation research. J Rehabil Res Dev (2013) 0.75
Focal Brain Injury Associated with a Model of Severe Hypoxic-Ischemic Encephalopathy in Nonhuman Primates. Dev Neurosci (2017) 0.75
The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat Neurosci (2004) 5.36
In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat Med (2005) 3.88
Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat Med (2006) 3.23
Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron (2003) 2.32
Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci (2005) 2.30
Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans? Nat Med (2007) 2.29
Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci (2002) 2.27
Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis (2008) 2.26
Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol (2005) 2.22
Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci (2003) 2.03
Nogo and its paRTNers. Trends Cell Biol (2003) 1.90
Nogo-A-deficient mice reveal strain-dependent differences in axonal regeneration. J Neurosci (2006) 1.89
Constraint-induced movement therapy in the adult rat after unilateral corticospinal tract injury. J Neurosci (2008) 1.65
Combined delivery of Nogo-A antibody, neurotrophin-3 and the NMDA-NR2d subunit establishes a functional 'detour' in the hemisected spinal cord. Eur J Neurosci (2011) 1.62
Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types. J Biol Chem (2005) 1.61
Rewiring of the corticospinal tract in the adult rat after unilateral stroke and anti-Nogo-A therapy. Brain (2013) 1.59
Reorganization of descending motor tracts in the rat spinal cord. Eur J Neurosci (2002) 1.55
Deep brain stimulation of the midbrain locomotor region improves paretic hindlimb function after spinal cord injury in rats. Sci Transl Med (2013) 1.53
Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays. Trends Neurosci (2003) 1.52
Sprouting, regeneration and circuit formation in the injured spinal cord: factors and activity. Philos Trans R Soc Lond B Biol Sci (2006) 1.48
Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats. J Cereb Blood Flow Metab (2005) 1.48
Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann Neurol (2002) 1.44
Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system. Ann Med (2005) 1.42
Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J Cereb Blood Flow Metab (2003) 1.42
A reticular rhapsody: phylogenic evolution and nomenclature of the RTN/Nogo gene family. FASEB J (2003) 1.42
Characterization of epidermal neural crest stem cell (EPI-NCSC) grafts in the lesioned spinal cord. Mol Cell Neurosci (2006) 1.38
Long-lasting sprouting and gene expression changes induced by the monoclonal antibody IN-1 in the adult spinal cord. J Neurosci (2002) 1.31
Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol (2004) 1.31
Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors. J Neurochem (2007) 1.30
Functional and anatomical reorganization of the sensory-motor cortex after incomplete spinal cord injury in adult rats. J Neurosci (2009) 1.28
Differential effects of anti-Nogo-A antibody treatment and treadmill training in rats with incomplete spinal cord injury. Brain (2009) 1.25
Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis. J Exp Med (2004) 1.25
Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4. J Mol Biol (2003) 1.23
Recovery and brain reorganization after stroke in adult and aged rats. Ann Neurol (2005) 1.23
Nogo-A stabilizes the architecture of hippocampal neurons. J Neurosci (2010) 1.22
The role of Nogo-A in axonal plasticity, regrowth and repair. Cell Tissue Res (2012) 1.22
Dendritic plasticity in the adult rat following middle cerebral artery occlusion and Nogo-a neutralization. Cereb Cortex (2005) 1.22
Rewiring of hindlimb corticospinal neurons after spinal cord injury. Nat Neurosci (2009) 1.20
Nogo-A and myelin-associated glycoprotein differently regulate oligodendrocyte maturation and myelin formation. J Neurosci (2008) 1.18
NogoA restricts synaptic plasticity in the adult hippocampus on a fast time scale. Proc Natl Acad Sci U S A (2011) 1.18
Chronic spinal hemisection in rats induces a progressive decline in transmission in uninjured fibers to motoneurons. Exp Neurol (2009) 1.18
Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey. J Comp Neurol (2007) 1.17
Synaptic destabilization by neuronal Nogo-A. Brain Cell Biol (2007) 1.17
Red nucleus projections to distinct motor neuron pools in the rat spinal cord. J Comp Neurol (2002) 1.16
Neuronal Nogo-A regulates neurite fasciculation, branching and extension in the developing nervous system. Development (2010) 1.13
Combination treatment with anti-Nogo-A and chondroitinase ABC is more effective than single treatments at enhancing functional recovery after spinal cord injury. Eur J Neurosci (2013) 1.12
Long-distance axonal regeneration induced by CNTF gene transfer is impaired by axonal misguidance in the injured adult optic nerve. Neurobiol Dis (2012) 1.10
The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep (2006) 1.09
Pincher-generated Nogo-A endosomes mediate growth cone collapse and retrograde signaling. J Cell Biol (2010) 1.09
Defeating inhibition of regeneration by scar and myelin components. Handb Clin Neurol (2012) 1.07
Neuronal Nogo-A modulates growth cone motility via Rho-GTP/LIMK1/cofilin in the unlesioned adult nervous system. J Biol Chem (2009) 1.06
Role of Nogo-A in neuronal survival in the reperfused ischemic brain. J Cereb Blood Flow Metab (2010) 1.06
Functional reorganization in rat somatosensory cortex assessed by fMRI: elastic image registration based on structural landmarks in fMRI images and application to spinal cord injured rats. Neuroimage (2008) 1.05
Delayed anti-nogo-a therapy improves function after chronic stroke in adult rats. Stroke (2010) 1.04
Intrathecally infused antibodies against Nogo-A penetrate the CNS and downregulate the endogenous neurite growth inhibitor Nogo-A. Mol Cell Neurosci (2006) 1.03
The rocky road to translation in spinal cord repair. Ann Neurol (2012) 1.02
Nogo-A is a negative regulator of CNS angiogenesis. Proc Natl Acad Sci U S A (2013) 1.02
Anti-Nogo-A antibody treatment promotes recovery of manual dexterity after unilateral cervical lesion in adult primates--re-examination and extension of behavioral data. Eur J Neurosci (2009) 1.02
Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke. Exp Brain Res (2007) 1.01
Nogo-A represses anatomical and synaptic plasticity in the central nervous system. Physiology (Bethesda) (2013) 1.00
Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions. Mol Cell Neurosci (2004) 0.99
Nogo-A expression after focal ischemic stroke in the adult rat. Stroke (2008) 0.99
Cell-autonomous mechanisms and myelin-associated factors contribute to the development of Purkinje axon intracortical plexus in the rat cerebellum. J Neurosci (2003) 0.98
Sequential loss of myelin proteins during Wallerian degeneration in the rat spinal cord. Glia (2003) 0.96
Nogo-a regulates neural precursor migration in the embryonic mouse cortex. Cereb Cortex (2010) 0.96
Distinct roles of Nogo-a and Nogo receptor 1 in the homeostatic regulation of adult neural stem cell function and neuroblast migration. J Neurosci (2012) 0.95
BMP2 and FGF2 cooperate to induce neural-crest-like fates from fetal and adult CNS stem cells. J Cell Sci (2005) 0.94
Do cancer cells die because of Nogo-B? Oncogene (2003) 0.94
Profiling locomotor recovery: comprehensive quantification of impairments after CNS damage in rodents. Nat Methods (2010) 0.94
Heterogeneous spine loss in layer 5 cortical neurons after spinal cord injury. Cereb Cortex (2011) 0.94
Functional reorganization of the motor cortex in adult rats after cortical lesion and treatment with monoclonal antibody IN-1. J Neurosci (2003) 0.93
Neuronal Nogo-A negatively regulates dendritic morphology and synaptic transmission in the cerebellum. Proc Natl Acad Sci U S A (2012) 0.93
Cognitive recovery in the aged rat after stroke and anti-Nogo-A immunotherapy. Behav Brain Res (2009) 0.92
Anti-Nogo-A antibody treatment does not prevent cell body shrinkage in the motor cortex in adult monkeys subjected to unilateral cervical cord lesion. BMC Neurosci (2008) 0.92
Neutralization of the membrane protein Nogo-A enhances growth and reactive sprouting in established organotypic hippocampal slice cultures. Eur J Neurosci (2008) 0.92
Constitutive genetic deletion of the growth regulator Nogo-A induces schizophrenia-related endophenotypes. J Neurosci (2010) 0.92
Nogo receptor antagonizes p75NTR-dependent motor neuron death. Proc Natl Acad Sci U S A (2008) 0.91
Lamina-specific restoration of serotonergic projections after Nogo-A antibody treatment of spinal cord injury in rats. Eur J Neurosci (2008) 0.91
Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expression. J Neurosurg (2007) 0.91
Nogo and Nogo receptor: relevance to schizophrenia? Neurobiol Dis (2013) 0.90
Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function. Proc Natl Acad Sci U S A (2013) 0.90
Sprouting of brainstem-spinal tracts in response to unilateral motor cortex stroke in mice. J Neurosci (2014) 0.89
Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury. J Cell Biol (2002) 0.89
Rehabilitative training following unilateral pyramidotomy in adult rats improves forelimb function in a non-task-specific way. Exp Neurol (2011) 0.89
Analysis of the reticulon gene family demonstrates the absence of the neurite growth inhibitor Nogo-A in fish. Mol Biol Evol (2005) 0.88
Electromyographic activity associated with spontaneous functional recovery after spinal cord injury in rats. Eur J Neurosci (2002) 0.88
A novel urodynamic model for lower urinary tract assessment in awake rats. BJU Int (2015) 0.87
Molecular analysis of Nogo expression in the hippocampus during development and following lesion and seizure. FASEB J (2003) 0.86
Identification of Nogo-66 receptor (NgR) and homologous genes in fish. Mol Biol Evol (2003) 0.86
Nogo-A inhibition induces recovery from neglect in rats. Behav Brain Res (2007) 0.85
Repair of the injured spinal cord. A joint approach of basic and clinical research. Neurodegener Dis (2007) 0.84
Anti-Nogo-A antibody: a treatment option for neurogenic lower urinary tract dysfunction? BJU Int (2015) 0.84
Tail spasms in rat spinal cord injury: changes in interneuronal connectivity. Exp Neurol (2012) 0.83
Motor deficits and recovery in rats with unilateral spinal cord hemisection mimic the Brown-Sequard syndrome. Brain (2011) 0.83
How hard is the CNS hardware? Nat Neurosci (2010) 0.83
Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders. J Neuroimmunol (2003) 0.82
Upregulation of axon guidance molecules in the adult central nervous system of Nogo-A knockout mice restricts neuronal growth and regeneration. Eur J Neurosci (2013) 0.81
Behavioral testing strategies in a localized animal model of multiple sclerosis. J Neuroimmunol (2004) 0.81